Initiation of Apixaban Versus Warfarin in Patients With Kidney Failure on Hemodialysis With Newly Diagnosed Atrial Fibrillation: A Target Trial Emulation

This publication has 23 references indexed in Scilit:

• Oral Anticoagulant Initiation in Patients With Kidney Failure on Hemodialysis Newly Diagnosed With Atrial Fibrillation (2007-2020): An Observational Study of Trends and Disparities
  Kidney Medicine, 2024
• Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes
  JAMA, 2023
• Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study
  American Journal of Kidney Diseases, 2022
• Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis
  Nephrology Dialysis Transplantation, 2018
• Safety and effectiveness of apixaban compared to warfarin in dialysis patients
  Research and Practice in Thrombosis and Haemostasis, 2018
• Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle
  Kidney International, 2018
• 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
  JACC, 2014
• Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples
  Statistics in Medicine, 2009
• Analyses of cumulative incidence functions via non‐parametric multiple imputation
  Statistics in Medicine, 2008
• Evaluating Medication Effects Outside of Clinical Trials: New-User Designs
  American Journal of Epidemiology, 2003